| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/29/2010 | US20100104511 Methods and compositions using chelator-antibody conjugates |
| 04/29/2010 | US20100104509 Human antibodies that bind cd19 and uses thereof |
| 04/29/2010 | US20100104508 Human antibodies that bind cxcr4 and uses thereof |
| 04/29/2010 | CA2741523A1 Human ebola virus species and compositions and methods thereof |
| 04/29/2010 | CA2741492A1 Combination treatments comprising protease binding proteins for inflammatory disorders |
| 04/29/2010 | CA2741435A1 Immunization protocol for directed expansion and maturation |
| 04/29/2010 | CA2741291A1 Lipidated imidazoquinoline derivatives |
| 04/29/2010 | CA2741127A1 Fibroblast growth factor receptor-3 (fgfr-3) inhibitors and methods of treatment |
| 04/29/2010 | CA2741087A1 Identification of signature genes associated with hepatocellular carcinoma |
| 04/29/2010 | CA2740856A1 Ligands that have binding specificity for dc-sign |
| 04/29/2010 | CA2740138A1 Methods for producing antibodies from plasma cells |
| 04/29/2010 | CA2739455A1 Antibodies that bind to il-12 and methods of purifying the same |
| 04/29/2010 | CA2739077A1 Antibodies that bind to il-18 and methods of purifying the same |
| 04/29/2010 | CA2738499A1 Viral inactivation during purification of antibodies |
| 04/29/2010 | CA2738001A1 Determination of immunoglobulin encoding nucleid acid |
| 04/28/2010 | EP2180054A1 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 04/28/2010 | EP2180044A1 Antibody glycosylation variants having increased anti-body-dependent cellular cytotoxicity |
| 04/28/2010 | EP2180041A2 New lines of human hepatomas, methods for obtaining same and applications thereof |
| 04/28/2010 | EP2180007A2 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 04/28/2010 | EP2179745A1 Combinations comprising epothilones and pharmaceutical uses thereof |
| 04/28/2010 | EP2179742A1 Compositions and methods for the treatment of immune related diseases |
| 04/28/2010 | EP2178920A1 An anti-cancer cytotoxic monoclonal antibody |
| 04/28/2010 | EP2178919A1 An anti-cancer cytotoxic monoclonal antibody |
| 04/28/2010 | EP2178918A1 An anti-cancer cytotoxic monoclonal antibody |
| 04/28/2010 | EP2178916A1 Human antibodies to human cd20 and method of using thereof |
| 04/28/2010 | EP2178915A2 Anti cd37 antibodies |
| 04/28/2010 | EP2178914A2 Monospecific and multispecific antibodies and method of use |
| 04/28/2010 | EP2178913A1 Antibody or fragment thereof recognizing avitag(tm) and uses thereof |
| 04/28/2010 | EP1673450B1 Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives |
| 04/28/2010 | EP1641828B1 Anti-hgf-r antibodies and their use |
| 04/28/2010 | EP1599228B1 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 04/28/2010 | EP1487854B1 Novel isoform of vascular endothelial cell growth inhibitor (vegi) |
| 04/28/2010 | EP1481062B1 Expec-specific proteins, genes encoding them and uses thereof |
| 04/28/2010 | EP1356067B1 Method for producing polyunsaturated fatty acids, novel biosynthesis genes and novel plant expression constructs |
| 04/28/2010 | EP1259606B1 Compositions useful for regulating parkin gene activity |
| 04/28/2010 | CN1940062B Liver-cancer stem cell, its separation and use |
| 04/28/2010 | CN1904041B Human recombination phospholipase D2, its preparation method and application in preparation medicine |
| 04/28/2010 | CN1813066B Novel beta-actin and rps21 promoters and uses thereof |
| 04/28/2010 | CN1796403B Polypeptide and bacterin for preventing and curing infection of polytype human being papilomavirus |
| 04/28/2010 | CN1767848B Survivin-derived peptides and use thereof |
| 04/28/2010 | CN1703426B Humanized antibodies that recognize beta amyloid peptide |
| 04/28/2010 | CN1650016B Method for modifying plant morphology, biochemistry and physiology including expression plant fission agent oxidase |
| 04/28/2010 | CN1596266B Specific binding agents of human angiopoietin-2 |
| 04/28/2010 | CN1468307B Anti-dual integrin antibodies, compositions, methods and uses |
| 04/28/2010 | CN101699288A Method for detecting microcystin-LR by self-assembly based on end face of gold nano-rod |
| 04/28/2010 | CN101698832A Production of gluten protein monoclonal antibody and application of cell strain thereof |
| 04/28/2010 | CN101698680A PEG-gelchromatography combined purification method for egg yolk immunoglobulins (IgY) |
| 04/28/2010 | CN101698673A Prawn white spot syndrome virus VP37p polypeptide fragment and application thereof |
| 04/27/2010 | USRE41277 protein D is an Ig receptor for human IgD and has an apparent molecular weight of 42,000; protein D can be detected in all of 116 encapsulated and non-encapsulated isolates of H. influenzae studied |
| 04/27/2010 | US7705195 Screening method |
| 04/27/2010 | US7705134 immunoglobulins; fibronectins; drug screening |
| 04/27/2010 | US7705133 Transient receptor potential cation channel for use in identifying modulators for prevention and treatment of cell proliferative and nervous system disorders; hybridoma cell line; radioimmunoassay; kits |
| 04/27/2010 | US7705132 Stable polypeptide formulations |
| 04/27/2010 | US7705131 Method for diagnosing selected adenocarcinomas |
| 04/27/2010 | US7705130 Human epidermal growth factor (HER) binding ligand for use in prevention and treatment of cell proliferative disorders |
| 04/27/2010 | US7705129 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 04/27/2010 | US7705123 Fusion protein contains antibody fragment, or Fc fragment; biodrug for use in the treatment and prevention of autoimmune and cancer diseases |
| 04/27/2010 | US7705121 Chimeric human T1R3 taste receptor polypeptides and compositions containing same |
| 04/27/2010 | US7705016 administering small molecule capable of inhibiting CPT1(carnitine palmitoyl transferase1) is 2-tetradecylglydate (TDGA) or (R)-N-(tetradecylcarbamoyl)-aminocarnitine |
| 04/27/2010 | US7704952 treating diabetes or obesity using isolated polypeptide is covalently modified with a water-soluble polymer |
| 04/27/2010 | US7704713 Polypeptides having DNA polymerase activity |
| 04/27/2010 | US7704513 Nucleic acids and polypeptides specific for pathogenic strains of the Neisseria genus |
| 04/27/2010 | US7704506 Fcε-PE chimeric protein for targeted treatment of allergy responses a method for its production and pharmaceutical compositions containing the same |
| 04/27/2010 | US7704505 preventing a respiratory syncytial virus (RSV) infection which is MAb1129 by administering to a human in need thereof an effective amount of a humanized anti-RSV antibody which contains the one CDR from each variable heavy and variable light chain of at least one murine monoclonal antibody |
| 04/27/2010 | US7704502 Combinations of antibodies selective for DR5 and other therapeutic agents |
| 04/27/2010 | US7704499 Antibody against fragments of apo-lipoprotein B; for immunization or therapeutic treatment of mammals, including humans, against ischemic cardiovascular diseases |
| 04/27/2010 | US7704498 Antiproliferative agents; anticancer agents; composition comprising antagonist of a human ErbB4 receptor, in admixture with a pharmaceutically acceptable carrier; antagonist selected from group consisting of an antibody produced by a hybridoma selected from the group containing HER4.10H1.1A1 |
| 04/27/2010 | US7704497 Molecules with extended half-lives, compositions and uses thereof |
| 04/27/2010 | US7704496 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
| 04/27/2010 | US7704490 inducing in a patient, at least one activity of IL-2 selected from increasing humoral immune responses and increasing cellular immune responses, by administering to said patient a therapeutically effective amount of a peptide sufficient to induce the activity |
| 04/27/2010 | CA2468479C Podophyllotoxins as antiproliferative agents |
| 04/27/2010 | CA2372400C Expression and export of interferon-alpha proteins as fc fusion proteins |
| 04/27/2010 | CA2328431C Plasmin inhibitors from the australian brown snake pseudonaja textilis textilis |
| 04/27/2010 | CA2323776C Cytokine receptor common gamma chain like |
| 04/27/2010 | CA2303202C Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins |
| 04/27/2010 | CA2192159C Nucleic acid sequences and expression systems for heparinase ii and heparinase iii derived from flavobacterium heparinum |
| 04/27/2010 | CA2179909C Ligand that binds fas antigen |
| 04/27/2010 | CA2162353C Interferon-.gamma. production inducing polypeptide, monoclonal antibody, and agent for interferon-.gamma. susceptive disease |
| 04/22/2010 | WO2010045589A2 Optimizing erythropoietin therapy |
| 04/22/2010 | WO2010045518A1 Compositions containing thrombomodulin domains and uses thereof |
| 04/22/2010 | WO2010045495A2 Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof |
| 04/22/2010 | WO2010045345A2 Treatment method |
| 04/22/2010 | WO2010045344A1 Combination therapy comprising a c-met antagonist and a vegf antagonist |
| 04/22/2010 | WO2010045261A1 Single chain fc type iii interferons and methods of using same |
| 04/22/2010 | WO2010045193A1 Immunoglobulin variants and uses thereof |
| 04/22/2010 | WO2010044506A2 Tmprss4-specific human antibody |
| 04/22/2010 | WO2010043977A2 Dengue virus neutralizing antibodies and uses thereof |
| 04/22/2010 | WO2010043650A2 Amino acid sequences directed against cellular receptors for viruses and bacteria |
| 04/22/2010 | WO2010043582A1 Method for the treatment of cancer |
| 04/22/2010 | WO2010043057A1 Bsa-specific antibodies |
| 04/22/2010 | WO2010043037A1 Formulations targeting igfbp7 for diagnosis and therapy of cancer |
| 04/22/2010 | WO2010022736A3 Recombinant anti-epidermal growth factor receptor antibody compositions |
| 04/22/2010 | WO2010017500A3 Anti-pancreatic cancer antibodies |
| 04/22/2010 | WO2009158618A3 Avian reoviridae |
| 04/22/2010 | WO2009155723A3 STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFα |
| 04/22/2010 | WO2009153670A3 Antibodies against domains of laminin-332 |
| 04/22/2010 | WO2009136286A9 Anti-il 17a/il-17f cross-reactive antibodies and methods of use thereof |
| 04/22/2010 | WO2009127414A3 Inhibition of angiogenesis and tumor metastasis |
| 04/22/2010 | WO2009126306A3 Compositions and methods for detecting egfr mutations in cancer |
| 04/22/2010 | WO2009120905A3 Immunoglobulin and/or toll-like receptor proteins associated with myelogenous haematological proliferative disorders and uses thereof |